Yang Guo

Dr. Yang Guo


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2019 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
YWYufeng Wang
Yufeng Wang
LYLiu Yang
Liu Yang
TCTianxiang Chen
Tianxiang Chen
XLXin Liu
Xin Liu
YGYang Guo
Yang Guo
KTKangsheng Tu
Kangsheng Tu
Hepatocellular carcinoma (HCC) is the most common malignant liver tumor with poor clinical outcomes. Increasing amount of long non-coding RNAs (lncRNAs) have been revealed to be implicated in the carcinogenesis and progression of HCC. However, the expressions, clinical significances, and roles of most lncRNAs in HCC are still unknown. The expression of lncRNA MCM3AP antisense RNA 1 (MCM3AP-AS1) in HCC tissues and cell lines was detected by qRT-PCR and fluorescence in situ hybridization. Immunoblotting, CCK-8, EdU, colony formation and flow cytometry were performed to investigate the role of MCM3AP-AS1 in HCC cell proliferation, cell cycle and apoptosis in vitro. A subcutaneous tumor mouse model was constructed to analyze in vivo growth of HCC cells after MCM3AP-AS1 knockdown. The interactions among MCM3AP-AS1, miR-194-5p and FOXA1 were measured by RNA pull-down, RNA immunoprecipitation and luciferase reporter assay. We revealed a novel oncogenic lncRNA MCM3AP-AS1, which is overexpressed in HCC and positively correlated with large tumor size, high tumor grade, advanced tumor stage and poor prognosis of HCC patients. MCM3AP-AS1 knockdown suppressed HCC cell proliferation, colony formation and cell cycle progression, and induced apoptosis in vitro, and depletion of MCM3AP-AS1 inhibited tumor growth of HCC in vivo. Mechanistically, MCM3AP-AS1 directly bound to miR-194-5p and acted as competing endogenous RNA (ceRNA), and subsequently facilitated miR-194-5p’s target gene forkhead box A1 (FOXA1) expression in HCC cells. Interestingly, FOXA1 restoration rescued MCM3AP-AS1 knockdown induced proliferation inhibition, G1 arrest and apoptosis of HCC cells. Our results recognized MCM3AP-AS1 as a novel oncogenic lncRNA, which indicated poor clinical outcomes in patients with HCC. MCM3AP-AS1 exerted an oncogenic role in HCC via targeting miR-194-5p and subsequently promoted FOXA1 expression. Our findings suggested that MCM3AP-AS1 could be a potential prognostic biomarker and therapeutic target for HCC.

1 November 2018 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
QXQiuran Xu
Qiuran Xu
CDChangwei Dou
Changwei Dou
XLXin Liu
Xin Liu
LYLiu Yang
Liu Yang
CNChao Ni
Chao Ni
DHDONGSHENG HUANG
DONGSHENG HUANG

21 April 2026 in Cancers
Verified
Journal Article
Open access
PDF file
TLTengfei Li
Tengfei Li
CXChengyuan Xu
Chengyuan Xu
YGYang Guo
Yang Guo
YXYanYan Xu
YanYan Xu
KCKaiji Chen
Kaiji Chen
MLMoubin Lin
Moubin Lin
Background: Midkine (MDK), a secreted heparin-binding growth factor, is involved in tumor progression and metastasis. While serum MDK is widely recognized as a potential prognostic biomarker for colorectal cancer (CRC), its specific functional role and underlying mechanisms in CRC development are not fully understood. Methods: The four publicly available CRC microarray datasets—GSE41258, GSE44076, GSE81558, and GSE117606—along with TCGA-COAD and TCGA-READ datasets and their associated clinical data were obtained. MDK expression was measured at both the mRNA and protein levels using quantitative real-time PCR (qRT-PCR) and Western blotting. To investigate its oncogenic functions, a comprehensive set of assays was performed: transwell and wound healing assays for invasion and migration; CCK-8 and colony formation assays for proliferation; and tail vein/spleen injection models combined with xenograft models to study metastasis and tumor growth in vivo. To uncover underlying mechanisms, Western blotting was used to examine the involvement of epithelial–mesenchymal transition (EMT) and the PI3K/AKT signaling pathway. Results: MDK is significantly overexpressed in CRC tissues and cells compared to normal tissues and cells. Notably, patients with high MDK levels show poorer overall survival (OS). Overexpression of MDK increases CRC invasion, migration, proliferation, and metastasis both in vivo and in vitro, while its knockdown reverses these effects. Mechanistically, MDK activates the PI3K/AKT pathway, leading to increased AP2A1 expression and promotion of EMT in CRC. Conclusions: MDK promotes invasion, migration, proliferation, metastasis, and EMT in CRC cells through the PI3K/AKT pathway by inducing AP2A1 expression, which could serve as a diagnostic marker. The PI3K inhibitor LY294002 significantly reduces AP2A1 levels and inhibits MDK-induced malignant behaviors. Targeting MDK-related signaling pathways may offer new strategies for CRC treatment.

28 March 2022 in Research Square
Verified
Preprint
Open access
PDF file
BZBo’an Zheng
Bo’an Zheng
WWWeiding Wu
Weiding Wu
XXXiaodong Xu
Xiaodong Xu
YJYuanming Jing
Yuanming Jing
XHXinye Hu
Xinye Hu
RCRui Chai
Rui Chai
With the development of modern society, human living standards have improved substantiallythus altering their lifestyles, particularly eating habits. These changes haveresulted in an increased incidence of colorectal cancer (CRC) in recent years. More than one million new cases of CRC are diagnosed worldwide and more than half a million deaths occur due to CRC, each year, making CRC the main cause of cancer-related mortality. In this study, we explored the role of myosin-related phosphatase 3 (MTMR3) in the invasion and metastasis of CRC by transfecting the human CRC cell line, HCT116 cells, with lentivirus-mediated short interfering RNA. A wound healing assay was performed to evaluate the effect of MTMR3 knockdown on cell migration ability. The effect of MTMR3 knockdown on the endothelial-mesenchymal transition and cell apoptosis was evaluated by western blot analysis. Our results indicate that knockdown MTMR3 significantly reduced the invasion and metastatic ability of HCT116 cells and promoted cell autophagy (p < 0.05).These results demonstrate that silencing of MTMR3 shows potential as an effective treatment for CRC.